The Good Men Project reposted an article from Futurity that reported on a study, co-authored by Jonathan Lovell, in which UB researchers are developing a recombinant flu vaccine that would offer several advantages over conventional vaccines.
Albert Titus has been named the associate vice president for regulatory support in the Office of the Vice President for Research and Economic Development.